Side Agreement: Definition, Terms, Example
Jump to Section
What is a Side Agreement?
A side agreement, sometimes called a side letter, or a side letter arrangement is an agreement that coincides with but is not part of a primary contract. Side agreements are often used for:
- Contingency agreements for a contract
- To clarify issues within a contract
- To provide variations of a contract
- For confidentiality
Side agreements typically take the form of a letter that is signed by both parties to the primary contract. Side agreements are subject to the same laws as contracts and to be legally binding must include an offer, acceptance, consideration, certainty, and the intention to create legal relations. A side agreement can also be made orally, however oral agreements are more difficult to prove and uphold in court.
Common Sections in Side Agreements
Below is a list of common sections included in Side Agreements. These sections are linked to the below sample agreement for you to explore.
Side Agreement Sample
Exhibit 10.34
Execution Copy
SIDE AGREEMENT
Reference is made to the (i) Exclusive License Agreement dated December 8, 2005 (the “License Agreement”) by and between the University of Iowa Research Foundation (“UIRF”) and OvaMed GmbH (“OvaMed” or “LICENSEE”), and (ii) exclusive Sublicense Agreement dated December 12, 2005, as amended (the “Sublicense Agreement”) by and between OvaMed and Coronado Biosciences, Inc., as successor to Asphelia Pharmaceuticals, Inc. (“Asphelia”) and Collingwood Pharmaceuticals, Inc. (“Coronado”).
WHEREAS, in connection with Coronado’s acquisition of certain assets of Asphelia in January 2011, Asphelia assigned to Coronado and Coronado assumed certain rights and obligations of Asphelia under the Sublicense Agreement and the Manufacturing and Supply Agreement effective March 29, 2006, as amended, between OvaMed and Asphelia (the “MSA”); and
WHEREAS, UIRF, OvaMed and Coronado (sometimes collectively referred to herein as the “Parties”) desire to clarify, amend or restate certain provisions of the License Agreement to reflect the current intentions of the Parties with respect to such agreement and to avoid any potential disputes under the License Agreement, and to provide for certain additional agreements of the Parties related to certain matters under the License Agreement and the Sublicense Agreement.
In view of the foregoing and for other good and valuable consideration, the adequacy and receipt of which are hereby acknowledged, effective as of November 15, 2011 (the “Effective Date”) the Parties hereby agree as follows:
1. Definitions and References. Except as set forth or amended herein, (a) capitalized terms used herein shall have the meaning ascribed to them in the License Agreement; and (b) references herein to Sections or Articles are to the same with all their subparts as they appear in the License Agreement.
2. Coronado as Sublicensee. Effective as of the Effective Date, the License Agreement is hereby amended as follows: all references therein to “Collingwood Pharmaceuticals, Inc.” “Collingwood”, “Asphelia Pharmaceuticals, Inc.” and/or “Asphelia” shall be changed to and construed as “Coronado Biosciences, Inc.” or “Coronado”, respectively, mutatis mutandis. The Parties acknowledge and confirm Coronado’s designation as SUBLICENSEE under the License Agreement.
3. Amendments to License Agreement. Effective as of the Effective Date, the License Agreement is hereby amended as set forth in this Paragraph 3:
(a) To clarify the definition of PATENT RIGHTS, the last sentence of Section 1.1 is hereby deleted in its entirety.
(b) To clarify the exclusive nature of the license granted under the License Agreement, the first sentence of Section 2.1 is hereby amended to delete the words “a license” and to replace such words with the words “an exclusive license”.
(c) To amend, clarify and conform certain diligence and reporting obligations:
(i) The first paragraph of Section 2.3(e) is hereby amended and restated to read in its entirety as follows:
“(e) LICENSEE shall use commercially reasonable efforts to (i) submit an IND to the FDA before July 31, 2012; (ii) commence a Phase 1 clinical trial with respect to a Licensed Product by January 1, 2013; (iii) commence a Phase 2 clinical trial with respect to a LICENSED PRODUCT by June 30, 2014; and (iv) submit an application for regulatory approval of LICENSED PRODUCT to the FDA within 16 months after successful completion of all testing and studies required by the FDA as a condition to or in connection with obtaining regulatory approval of LICENSED PRODUCT in the United States (each, an “Article 2.3 Milestone”); provided, however, that an Article 2.3 Milestone may be achieved or satisfied by SUBLICENSEE”.
(ii) The second paragraph of Section 2.3(e) is hereby amended to delete therefrom in each instance the words “Article 2.4 Milestone” and replace such words with the words “Article 2.3 Milestone”.
(iii) Section 4.1 is hereby amended to (A) insert the following sentence immediately prior to the last sentence thereof: “Notwithstanding the foregoing, subsequent to the filing of an IND, such annual reports may instead be provided within sixty (60) days after the submission to the FDA of the annual report in connection with the periodic reporting requirement for the IND and may be in form and substance similar to development plans employed by LICENSEE in the ordinary course of its business” and (B) delete therefrom in each instance the words “Section 2.4 (e)” and replace such words with the words “Section 2.3 (e)”.
(d) A new Section 4.3 is hereby added immediately following Section 4.2 to read in its entirety as follows:
“4.3 Purposely Omitted”
(e) The following new Section 9.11 is hereby added immediately following Section 9.10:
“9.11 In the event of a breach or default by LICENSEE in a particular country or jurisdiction in the TERRITORY which breach or default would give UIRF the right, pursuant to the provisions of this Agreement, to terminate this Agreement, such right shall, notwithstanding such provisions, be limited to a right to terminate this Agreement solely with respect to the particular country or jurisdiction to which the breach or default relates. In the event of a breach or default or termination of this Agreement in a particular country or jurisdiction in accordance with the foregoing sentence, the rights and obligations relating to or arising from such breach, default or termination shall be applicable to the country or jurisdiction to which the breach, default or termination relates.”
2
4. Additional Agreements among the Parties.
(a) Coronado and OvaMed hereby agree that, provided OvaMed has not breached its obligations under the Sublicense Agreement or the MSA, Coronado agrees to be bound by the terms of Section 2.3(e) of the License Agreement, as amended by this Amendment, to the extent applicable to the Territory (as defined in the Sublicense Agreement) and Coronado’s rights under the Sublicense Agreement.
(b) In satisfaction of and in accordance with the provisions of Section 9.5, the License Agreement shall be assigned to Coronado as SUBLICENSEE upon termination of the License Agreement and UIRF shall accept and honor such assignment.
(c) Subject to the provisions of this Paragraph 4(), in the event of any breach or default by LICENSEE under the License Agreement which breach or default gives UIRF the right to terminate the License Agreement (in its entirety or, in accordance with Section 9.11, in a particular country or jurisdiction), the following shall be applicable:
(i) UIRF shall provide Coronado with written notice of such breach (and, as applicable, failure to cure such breach or intent to terminate), in addition to any notice thereof provided to LICENSEE, which notice shall disclose the nature and amount of the breach;
(ii) If the breach is of a curable obligation, Coronado shall have the right, but not the obligation, to cure such breach within sixty (60) days after receiving such written notice if the breach relates to a payment obligation or within ninety (90) days after receiving such written notice if the breach relates to any other material obligation; provided that if Coronado cures such breach within the applicable periods, (A) any payments by Coronado to UIRF to cure such breach shall discharge the related payment obligation LICENSEE may have had to UIRF; (B) Coronado may, but shall not be obligated to, make future payments required to be made by LICENSEE to UIRF under the License Agreement directly to UIRF; (C) OvaMed shall reimburse Coronado for any such payments made by Coronado to UIRF and any other costs associated with curing such breach (or, at Coronado’s option, Coronado shall be permitted to set off such payments and costs against amounts payable by Coronado to OvaMed under the Sublicense Agreement or the Supply Agreement); and (D) UIRF shall not have the right to terminate the License Agreement as a result of such breach; and
(iii) If the breach is of a non-curable obligation, and Coronado has not caused such LICENSEE breach (it being understood that Coronado will not be deemed to have caused such breach if OvaMed has breached its obligations to Coronado under the Sublicense Agreement or the MSA), Coronado shall have the right, but not the obligation, to have the License Agreement survive, provided that from and after any such election by Coronado, (A) LICENSEE’s rights, licenses and obligations in the License Agreement shall be deemed assigned to and assumed by Coronado on the same terms and conditions as set forth in the License Agreement; (B) all references to LICENSEE in the License Agreement shall be construed as Coronado; and (C) UIRF shall not have the right to terminate the License Agreement as a result of such breach.
3
5. Validity of License Agreement. The License Agreement is valid and in full force and effect in accordance with its terms and there are no breaches, defaults in the performance of any obligation thereunder, or other acts or events which would (with or without notice, the passage of time, or both) constitute a breach or default or otherwise give rise to any right by UIRF to terminate or render non-exclusive the License Agreement. From and after the Effective Date, all references to the License Agreement shall mean the License Agreement as amended or supplemented by this Side Agreement.
6. Miscellaneous.
(a) Notices provided hereunder to be given by a Party to any other Party shall be in writing and shall be sent by fax or email (and confirmed by personal delivery, registered or certified mail or overnight courier), or delivered by recognized overnight delivery service or sent by government mail service (certified or registered air mail) to the following respective addresses or to such other addresses as the Parties may hereafter communicate to each other in writing:
If to Coronado:
Coronado Biosciences, Inc.
15 New England Executive Park
Burlington, MA 01803, USA
Attention: Chief Executive Officer
Fax No.: 781-459-7788
If to OvaMed:
OvaMed GmbH.
Kiebitzhörn 31
22885 Barsbuttel, Germany
Attention: Chief Executive Officer
Fax No.: +49 40 675 095 58
If to UIRF:
University of Iowa Research Foundation
214 Technology Innovation Center
Iowa City, Iowa 52242-5000, USA
Attention: Executive Director
Fax No: 319-335-4486
(b) This Side Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures to this Side Agreement transmitted by fax, by email in “portable document format” (“.pdf”) or by any other electronic means intended to preserve the original graphic and pictorial appearance of this Side Agreement shall have the same effect as physical delivery of the paper document bearing an original signature.
4
IN WITNESS WHEREOF, the Parties have executed this Side Agreement as of the Effective Date.
| UNIVERSITY OF IOWA RESEARCH FOUNDATION | ||
| BY: | /s/ Zev Sunleaf | |
| NAME: | Zev Sunleaf | |
| TITLE: | Interim Executive Director | |
| CORONADO BIOSCIENCES, INC. | ||
| BY: | /s/ Bobby W. Sandage, Jr., Ph.D | |
| NAME: | Bobby W. Sandage, Jr., Ph.D | |
| TITLE: | President and Chief Executive Officer | |
| OVAMED GMBH | ||
| BY: | /s/ Detlev Goj | |
| NAME: | Detlev Goj | |
| TITLE: | Director |
| BY: | /s/ Alexander Beese | |
| NAME: | Alexander Beese | |
| TITLE: | Director |
5
Reference:
Security Exchange Commission - Edgar Database, EX-10.34 4 d273446dex1034.htm SIDE AGREEMENT, Viewed October 12, 2021, View Source on SEC.
Who Helps With Side Agreements?
Lawyers with backgrounds working on side agreements work with clients to help. Do you need help with a side agreement?
Post a project in ContractsCounsel's marketplace to get free bids from lawyers to draft, review, or negotiate side agreements. All lawyers are vetted by our team and peer reviewed by our customers for you to explore before hiring.
ContractsCounsel is not a law firm, and this post should not be considered and does not contain legal advice. To ensure the information and advice in this post are correct, sufficient, and appropriate for your situation, please consult a licensed attorney. Also, using or accessing ContractsCounsel's site does not create an attorney-client relationship between you and ContractsCounsel.
Meet some of our Side Agreement Lawyers
Lauren W.
Accident and injury attorney. Prior to going to law school I was a paralegal for 12+ years primarily in personal injury. I also worked for a local school district as the Risk Manager and a Buyer in Procurement where I facilitated solicitations and managed all the contracts for the district.
"Lauren reviewed my prenup promptly, gave good feedback, and was pleasant to work with."
Brian R.
Brian M. Rokaw has negotiated, drafted, and reviewed a multitude of contracts, resolutions, and agreements for a wide array of business owners. Brian has represented clients who are starting a business, selling a business, buying a business, creating a partnership, establishing a corporate entity, as well as those that are dissolving a business throughout the State of Florida. Brian M. Rokaw is knowledgeable and experienced in all real estate related matters, both residential and commercial including closings, financing, and litigation. Brian has drafted hundreds of deeds, affidavits, bills of sale, and settlement statements. Brian has represented clients in all areas of the real estate industry, including buyers, sellers, developers, management companies, brokers, and investors throughout the State of Florida. Brian M. Rokaw has successfully defended against actions and negotiated settlement agreements involving all types of consumer debt. Brian has represented homeowners and commercial property owners that are facing foreclosure, being pursued by judgment creditors, consumers burdened by secured and unsecured financial obligations, as well as collection accounts throughout the State of Florida.
Daniel R.
NY Admitted Lawyer 20+ years of experience. Focused on Startups , Entrepreneurs, Entertainers, Producers, Athletes and SMB Companies. I have been a part of numerous startups as Founder, CEO, General Counsel and Deal Executive. I have been through the full life cycle from boot strap to seed investors to large funds-public companies to successful exit. Let me use my experiences help you as you grow your business through these various stages. We saw a market for an on-line platform dedicated to Virtual General Counsel Services to Start Ups and Private Companies.
"Daniel did an excellent job, was very responsive, and I highly recommend his services."
Matthew S.
Attorney with a wide-range of experience
"Matthew is exceptionally timely. He had a response back to me three days before the due date. He is easy to work with and an excellent communicator. If I ever need assistance in the future, I will reach out to Matthew."
Jaime H.
20 years experienced attorney. Practice areas LLC & Corp/Deeds/ Contracts/Wills Trusts/
"Todd was excellent. Smart, responsive, fast, and accurate. Very pleased!"
December 27, 2022
Adjckwc B.
A. Browne Esq. is an entertainment, intellectual property, and business lawyer. Her goal is always to provide the best legal representation for your creative endeavors, both tangible and intangible. Always know that the best way to deal with legal issues is to take measures to avoid them. Learn how to protect your creative work at a law firm that’s passionate about ensuring that creatives own their stuff.
January 11, 2023
Christopher N.
Christopher Nuneviller has practiced in the securities, venture capital, corporate and emerging business sectors, and as a contract-advisor to the federal government, a federal government senior level executive, and as Army Judge Advocate. Like you, he also he is a partner in other business ventures and faces the same pressure to succeed, be profitable, and stay sane, all while making his clients, employees, family and business partners happy. As the managing partner for Philadelphia's MNB Meridian Law, Ltd., his focus is on assisting small and mid-sized businesses grow and thrive. As a business generalist, Christopher provides advice and counsel to businesses, their owners, investors and shareholders on matters ranging from formation, organization, governance, routine and special operations, and growth toward IPO. Christopher is also a former U.S. Army Judge Advocate having served seven years in Washington, D.C. where he gained significant experience with "above the fold" matters of great import and an unhealthy insight into the internal workings of the "beltway" underbelly. Mr. Nuneviller is admitted to practice in the Commonwealth of Pennsylvania, and before the Supreme Court of the United States, the Court of Federal Claims, and the Court of Appeals for the Armed Forces.
Find the best lawyer for your project
Browse Lawyers Now
Quick, user friendly and one of the better ways I've come across to get ahold of lawyers willing to take new clients.
View Trustpilot ReviewHow It Works
Business lawyers by top cities
- Austin Business Lawyers
- Boston Business Lawyers
- Chicago Business Lawyers
- Dallas Business Lawyers
- Denver Business Lawyers
- Houston Business Lawyers
- Los Angeles Business Lawyers
- New York Business Lawyers
- Phoenix Business Lawyers
- San Diego Business Lawyers
- Tampa Business Lawyers
Side Agreement lawyers by city
- Austin Side Agreement Lawyers
- Boston Side Agreement Lawyers
- Chicago Side Agreement Lawyers
- Dallas Side Agreement Lawyers
- Denver Side Agreement Lawyers
- Houston Side Agreement Lawyers
- Los Angeles Side Agreement Lawyers
- New York Side Agreement Lawyers
- Phoenix Side Agreement Lawyers
- San Diego Side Agreement Lawyers
- Tampa Side Agreement Lawyers
Contracts Counsel was incredibly helpful and easy to use. I submitted a project for a lawyer's help within a day I had received over 6 proposals from qualified lawyers. I submitted a bid that works best for my business and we went forward with the project.
View Trustpilot Review
I never knew how difficult it was to obtain representation or a lawyer, and ContractsCounsel was EXACTLY the type of service I was hoping for when I was in a pinch. Working with their service was efficient, effective and made me feel in control. Thank you so much and should I ever need attorney services down the road, I'll certainly be a repeat customer.
View Trustpilot Review
I got 5 bids within 24h of posting my project. I choose the person who provided the most detailed and relevant intro letter, highlighting their experience relevant to my project. I am very satisfied with the outcome and quality of the two agreements that were produced, they actually far exceed my expectations.
View Trustpilot Review